Why Prescription Drug Prices Keep Rising in the U.S.

 Although the Trump administration repeatedly promised to lower drug prices, the reality has been starkly different: prescription costs continue to climb, leaving Americans struggling while pharmaceutical companies thrive. Behind these soaring prices are CEOs inflating their paychecks, corporations shielded by government-funded research, and generous tax breaks that keep profits flowing.

The system is built to favor Big Pharma. Life-sustaining drugs like insulin illustrate the problem most starkly: patients are forced into impossible choices—buy medicine or pay rent. A deeper understanding of this system is needed to uncover where all the money goes.

The path to affordable medicine requires meaningful drug-pricing reform. Many of us have seen examples where people cannot afford necessary medications. Below are the main drivers of high drug prices:

1. Drug makers’ profit motive

Pharmaceutical companies argue that drug development and clinical trials are expensive and risky, with many failures along the way. Yet a recent JAMA Network Open study found no connection between R&D spending and drug prices. Even after accounting for R&D costs, most of the top 30 pharmaceutical companies report billions in profit. In Europe, where drug prices are negotiated, the same medicines often cost far less.

2. Pharmacy benefit managers (PBMs)

PBMs manage drug benefits for large employers, Medicare, and insurers, deciding which drugs to cover and how much patients pay. Their incentives—often tied to a percentage of overall spending—can encourage approval of higher-priced drugs. State and federal lawmakers are increasingly pushing for legislation to limit PBM influence and increase transparency.

3. Cost-sharing

Insurers have shifted more costs onto patients through higher copays, deductibles, and premiums. While sometimes justified as a way to discourage unnecessary care, this system often deters people from seeking essential treatment.

4. Legal maneuvers

Drug makers extend monopolies by filing multiple patents, suing potential competitors, or creating “me too” drugs with minor tweaks to secure new protections. Others acquire patents for older drugs, then sharply raise prices, or merge with rivals to suppress competition.

5. Direct-to-consumer advertising

Drug companies spend billions—nearly $8.1 billion in 2022—on advertising, which raises drug costs while fueling demand for newer, heavily marketed (and often more expensive) drugs. Most countries ban this practice; the U.S. remains a major exception.

What Might Slow Rising Drug Costs?

While prescription drug prices are unlikely to fall dramatically anytime soon, several developments could help curb costs:

• The Inflation Reduction Act of 2022. This law allows the U.S. government to negotiate prices for certain Medicare drugs, beginning with 10 high-cost medications in 2026. More will follow annually, though the scope remains limited given that over 20,000 drugs are on the market.
• Drug importation and new legislation. The FDA recently approved Florida’s plan to import drugs from Canada. Additional proposals at both state and federal levels aim to expand access to lower-cost alternatives.
• Advocacy efforts. Organizations such as AARP, Consumers Union, and Patients for Affordable Drugs are amplifying public pressure on lawmakers, gaining more traction now than in the past.

Conclusion

According to Dr. Robert Shmerling, former clinical chief of rheumatology at Beth Israel Deaconess Medical Center, the U.S. healthcare system is structurally designed to reward high drug prices. While individuals can take steps to reduce their out-of-pocket expenses, these efforts have limits. Real progress requires systemic reform that removes middlemen and eliminates incentives that inflate costs without adding value.

Until then, the most effective step individuals can take may be preventive: staying as healthy as possible to reduce reliance on prescription drugs. After all, the surest way to lower drug costs is not to need them at all.

 Reference:

https://www.health.harvard.edu/blog/why-do-your-prescription-drugs-cost-so-much-202401183007